Suchergebnisse - "Tan, Qiaoyun"

PubPharm (31)

11

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Tan, Q. | Dai, L. | Wang, Y. | +20

12

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

enthalten in: Cancer immunology immunotherapy | 2022

von Lou, N. | Zheng, C. | Wang, Y. | +7

13

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

enthalten in: Cancer immunology immunotherapy | 2022

von Lou, N. | Zheng, C. | Wang, Y. | +7

14

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

enthalten in: Cancer immunology immunotherapy | 2022

von Lou, N. | Zheng, C. | Wang, Y. | +7

15

High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes

enthalten in: Cancer science | 2022

von Luo, R. | Zheng, C. | Song, W. | +3

16

Development and validation of a UPLC-MS/MS method to quantitate anti-PD1 monoclonal antibody (Toripalimab), and comparison with electrochemiluminescence immunoassay

enthalten in: Journal of pharmaceutical and biomedical analysis | 2022

von Liu, S. | Yang, J. | Yang, S. | +8

17

Case report : A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review

enthalten in: Frontiers in oncology | 2022

von Tan, Q. | Liu, L. | Huang, Y. | +2

18

Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patients

enthalten in: Cytokine | 2022

von Zhang, N. | Tan, Q. | Tao, D. | +9

19

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypes

enthalten in: Cancer Science | 2022

von Luo, R. | Zheng, C. | Song, W. | +3

20

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology immunotherapy | 2021

von Tan, Q. | Dai, L. | Wang, Y. | +20